Navidea生物制药(NAVB)

0.0360 0.0010 2.857143%

今开:0.035昨收:0.035
最高:0.04545 最低:0.03
涨停价:0.0跌停价:0.0
总市值:3603038.0

Navidea生物制药的最新讨论

兔斯基不吃面2020-05-22 20:26

$Navidea生物制药(NAVB)$ 下一个轮到ABUS生物制药哈哈哈,异曲同工查看全文

荣耀之战2020-05-22 06:41

$Navidea生物制药(NAVB)$ 盘后什么消息了?查看全文

小水大雨2019-12-31 01:40

$Navidea生物制药(NAVB)$ 未来几天, 估计持续上涨的机率比较大。 但是交易量很低的小盘股, 知适合很小的资金投机一下。 买了200股, 试试运气[干杯]查看全文

用户48783635432019-04-09 14:29

【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文

艾萨克的猫2018-10-23 23:00

$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文

1 2

Navidea生物制药的公告

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-23 AccNo: 0001564590-16-015173 Size: 14 MB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-03-18 AccNo: 0001193125-16-510514 Size: 95 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-03-18 AccNo: 0001144204-16-088963 Size: 180 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2016-03-16 AccNo: 0001144204-16-088503 Size: 27 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-03-09 AccNo: 0001193125-16-497413 Size: 128 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-03-02 AccNo: 0001144204-16-085585 Size: 21 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-01-13 AccNo: 0000000000-16-061280 Size: 35 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ UPLOAD [Cover] - SEC-generated letter Filed: 2015-12-31 AccNo: 0000000000-15-060019 Size: 157 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ CORRESP [Cover] - Correspondence Filed: 2016-01-11 AccNo: 0001144204-16-075044 Size: 13 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-02-11 AccNo: 0001144204-16-080613 Size: 18 KBItem 7.01: Regulation FD Disclosure 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48